CD19 Targeted Chimeric Antigen Receptor T Cells for B Cell Lymphoma

计划入组 50 人 · 首次发布于 2017 年 4 月 18 日

Claudin 18.2-Targeted Chimeric Antigen Receptor T-cells for Gastric/Gastroesophageal Junction Adenocarcinoma

计划入组 12 人 · 首次发布于 2024 年 4 月 8 日

CD276-targeted Chimeric Antigen Receptor T Cells in Treatment With Advanced Pancreatic Cancer

计划入组 10 人 · 首次发布于 2021 年 12 月 3 日

ICT19G1

Anti-CD19 UCAR-T cells

MANA-312

ANTIGEN LABORATORIES INC.

United States

TARGETED GENETICS CORPORATION

United States

UNION MULTI CULTURES GUADELOUPEENNE

Guadeloupe

Multi-Antigen T Cell Therapy Shows 84.6% Disease Control Rate in Pancreatic Cancer Phase 1/2 Trial

Advancements in PSMA-Targeted Radionuclide Therapy for Metastatic Prostate Cancer

Multi-Antigen T Cell Therapy Shows Safety and Durable Responses in Pediatric Brain Tumors: Phase 1 ReMIND Trial